Tag: drug development
Lunit takes pathology AI into drug research with US lab pact
Cancer pathology software from Lunit, a Korean medical AI company, is headed into pharmaceutical research. A partnership with Discovery Life…
US agency bets on digital twins to reinvent clinical trials
A new ARPA-H program aims to simulate trials in silico and cut the number of patients needed.
Enveda lands $311M to move three medicines into late-stage trials
Enveda closed a $311 million Series E led by Catalio to push three clinical-stage medicines deeper into development.
nPhase.ai takes on clinical trial data with agentic workflows
The REDCap Cloud maker says its new platform moves raw trial data to submission-ready files in weeks.
Takeda uses Weave Bio AI to draft drug filings 97% faster
Takeda runs Weave Bio's regulatory AI across 14 drug programs, cutting first-draft filing time by 97%.
Faro banks $37.3M to put AI agents inside clinical trials
Agentic AI platform for clinical development closes a $37.3M Series B led by Merck's health fund and S32.
Startup keeps donated skin alive to train its biology AI
Outer Biosciences sustains surgically discarded tissue for a month to build better models.
TCS launches agentic AI hub for clinical trials and drug safety
TCS launches an agentic AI hub that brings governed agents to clinical trials and drug safety work.